Goldman Jonathan sold AVTX
November 14, 2025 · Form 4 insider transaction
Goldman Jonathan sold 8,200 shares of Avalo Therapeutics, Inc. at $14.35 per share, a transaction worth $117.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,200
Price
$14.35
Total value
$117.6K
InsiderGoldman Jonathan
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 14, 2025
Filing dateNovember 17, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were sold in multiple transactions at prices ranging from $14.02 to $14.60. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.